Ferda HOSGORLER, Oğuz ÇETİNAYAK, Ülker CANKURT, Didem KELEŞ, Gülgün OKTAY, Zekiye AYDOĞDU, Mustafa AKHISAROGLU, Sevil GÖNENÇ ARDA, Serpil TANRIVERDI AKHISAROGLU, Seniz İNANC, Ahmet Deniz UÇAR

Anti-inflammatory and Anti-apoptotic Effect of Valproic Acid and Doxycycline Independent from MMP Inhibition in Early Radiation Damage

ackground: Matrix metalloproteinase (MMP) inhibi-tors decrease inflammation in normal tissues and sup-press cancer progress in normal tissues. Valproic acid (VA) and doxycycline (DX) are MMP inhibitors that have radio-protective effects. Their ability to inhibit MMPs in irradiated tissue is unknown and the role of MMPs in radio-protective effects has not been tested to date.Aims: The purpose of this study was to examine wheth-er administration of VA and DX to rats before irradia-tion affects tissue inflammation and apoptosis in the early phase of radiation, and whether the effect of these drugs is mediated by MMP inhibition.Study Design: Animal experimentation.Methods: Twenty-six Wistar rats were randomized into four groups: control (CTRL), radiation (RT), VA plus radiation (VA+RT), and DX plus radiation (DX+RT).Three study groups were exposed to a single dose of abdominal 10 Gy gamma radiation; the CTRL group received no radiation. Single doses of VA 300 mg/kg and DX 100 mg/kg were administered to each rat be-fore radiation and all rats were sacrificed 8 hours after irradiation, at which point small intestine tissue sam-ples were taken for analyses. Levels of inflammatory cytokines (TNF-?, IL-1?, and IL-6) and matrix metal-loproteinases (MMP-2 and MMP 9) were measured by ELISA, MMP activities were measured by gelatin and casein zymography and apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling assay.Results: VA decreased the levels of TNF-? and IL-1? proteins insignificantly and decreased apoptosis sig-nificantly in the irradiated tissue, but did not inhibit MMPs. In contrast, VA protected the basal MMP activi-ties, which decreased in response to irradiation. No ef-fect of DX was observed on the levels of inflammatory cytokines or activities of MMPs in the early phases of radiation apoptosis.Conclusion: Our findings indicated that VA protects against inflammation and apoptosis, and DX exhibits anti-apoptotic effects in early radiation and these ef-fects are independent from MMP inhibition

PDF

___

Linard C, Ropenga A, Vozenin-Brotons M.C, Chapel A, Mathe D. Abdominal irradiation increases inflammatory cytokine expression and activates NF-kappaB in rat ileal muscularis layer. Am J Physiol Gastrointest Liver Physiol 2003;285:G556-65. [CrossRef]
Paris F., Fuks Z., Kang A., Capodieci P., Juan G., Ehleiter D., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001;293:293-7. [CrossRef]
Angenete E., Langenskiöld M., Falk P., Ivarsson M.L. Matrix me- talloproteinases in rectal mucosa, tumour and plasma: response af- ter preoperative irradiation. Int J Colorectal Dis 2007;22:667-74. [CrossRef]
Strup-Perrot C., Vozenin-Brotons M.C., Vandamme M., Linard C., Mathé, D. Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells. World J Gastroenterol 2005;11:6312-21. [CrossRef]
Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I.B., Eng- hild JJ., et al. Degradation of interleukin 1beta by matrix metal- loproteinases. J Biol Chem 1996;271:14657-60. [CrossRef]
Mohan MJ, Seaton T, Mitchell J, Howe A, Blackburn K, Burkhart W, et al. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 2002;4:9462-9. [CrossRef]
Nascimento GC, Rizzi E, Gerlach RF, Leite-Panissi CR. Expres- sion of MMP-2 and MMP-9 in the rat trigeminal ganglion during the development of temporomandibular joint inflammation. Braz J Med Biol Res 2013;46:956-67. [CrossRef]
Shen LC, Chen YK, Lin LM, Shaw SY. Anti-invasion and anti- tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma-in vitro and in vivo studies. Oral Oncol 2010;46:178-84. [CrossRef]
Lee JY, Kim HS, Choi HY, Oh TH, Ju BG, Yune TY. Valproic acid attenuates blood-spinal cord barrier disruption by inhibit- ing matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury. J Neurochem 2012;121:818- 29. [CrossRef]
Papi A, Ferreri AM, Rocchi P, Guerra F, Orlandi M. Epigenetic modifiers as anticancer drugs: effectiveness of valproic acid in neural crest-derived tumor cells. Anticancer Res 2010;30:535-40.
Chung YL, Wang AJ, Yao LF. Antitumor histone deacetylase in- hibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. Mol Cancer Ther 2004;3:317-25.
Epperly MW, Chaillet JR, Kalash R, Shaffer B, Goff J, Franicola D, et al. Conditional radioresistance of Tet-inducible manganese superoxide dismutase bone marrow stromal cell lines. Radiat Res 2013;180:189-204. [CrossRef]
Panés J, Mollà M, Casadevall M, Salas A, Sans M, Conill C, et al. Tepoxalin inhibits inflammation and microvascular dysfunc- tion induced by abdominal irradiation in rats. Aliment Pharma- col Ther 2000;14:841-50. [CrossRef]
Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of tran- sient focal cerebral ischemia: the roles of HDAC and MMP-9 in- hibition. J Cereb Blood Flow Metab 2011;31:52-7. [CrossRef]
Grant K. DOXYCYLINE. Rat Medication Guide. 2003 June 23 (cited 2010 January 19): Available from: http://ratguide.com/ meds/antimicrobial_agents/doxycycline.php
Heussen C, Dowdle EB. Electrophoretic analysis of plas- minogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202. [CrossRef]
Kerr JF, Winterford CM, Harmon BV. 1994. Apoptosis. Its sig- nificance in cancer and cancer therapy. Cancer 1994;73:2013- 26. [CrossRef]
Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C, et al. In situ apoptotic cell labeling by the TU- NEL method: improvement and evaluation on cell preparations. J Histochem Cytochem 1996;44:959-68. [CrossRef]
Lee WH, Warrington JP, Sonntag WE, Lee YW. Irradiation al- ters MMP-2/TIMP-2 system and collagen type IV degradation in brain. Int J Radiat Oncol Biol Phys 2012;82:1559-66. [CrossRef]
Medina C, Radomski MW. Role of matrix metalloproteinases in intestinal inflammation. Pharmacol Exp Ther 2006;318:933-38. [CrossRef]
Hovdenak N, Wang J, Sung CC, Kelly T, Fajardo LF, Hauer-Jensen M. Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 2002;53:919-27. [CrossRef]
Kumar A, Collins HM, Scholefield JH, Watson SA. Increased type-IV collagenase (MMP-2 and MMP-9) activity follow- ing preoperative radiotherapy in rectal cancer. Br J Cancer 2000;82:960-5. [CrossRef]
Kim NY, Lee JE, Chang HJ, Lim CS, Nam DH, Min BH, et al. Gamma-irradiation enhances RECK protein levels in Panc-1 pancreatic cancer cells. Mol Cells 2008;25:105-11.
Lint VP, Libert C. Chemokine and cytokine processing by ma- trix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007;82:1375-80. [CrossRef]
Manicone AM, McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008;19:34-41. [CrossRef]
Zhou Y, Niu J, Li S, Hou H, Xu Y, Zhang W, et al. Radioprotec- tive effects of valproic acid, a histone deacetylase inhibitor, in the rat brain. Biomed Rep 2015;3:63-9.
Zhou Y, Xu Y, Wang H, Niu J, Hou H, Jiang Y. Histone deacety- lase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line in vitro. Oncol Lett 2014;7:203-8.
Jantzie LL, Todd KG. Doxycycline inhibits proinflammatory cyto- kines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats. J Psychiatry Neurosci 2010;35:20-32. [CrossRef]
Samtani S, Amaral J, Campos MM, Fariss RN, Becerra SP. Dox- ycycline-mediated inhibition of choroidal neovascularization. In- vest Ophthalmol Vis Sci 2010;50:5098-106. [CrossRef]